Pharmaceutical Supply Chain Planning
A pharma batch is committed months before it is packed for a market, and its shelf life starts the day it is made. DemandLabs plans drug substance, drug product and pack on one model, with a service target for each market and expiry in view.
What Shapes Pharma and Biotech Planning
Pharma and biotech supply passes through several stages, sites and markets before a pack reaches a patient.
Each Batch Commits Months Ahead
Drug substance, synthesized or grown in a bioreactor, runs in campaigns before formulation and packaging, often at different sites. Testing and release add time at each step, so starts are set months ahead.
One Batch, Many Market Packs
The same tablet or vial is packed into country packs with their own language, label and pack size. Once packed for one market, stock usually cannot be sold in another.
Markets Want Remaining Shelf Life
Many customers and markets require a minimum remaining shelf life when stock arrives, so a batch held too long at the plant or a central warehouse reaches the market short-dated.
Solutions for Pharma and Biotech
The DemandLabs applications that fit pharma and biotech, and how each one handles the planning.
Drug substance, formulation and packaging capacity solve together across your own sites and contract manufacturers, with changeovers between products and minimum batch sizes in the same run.
Explore supply planningEach market carries its own service target, with the stock that target needs shown before packs are committed. Short-dated packs show in the aging view by remaining shelf life, each with a recovery play while it can still sell.
Explore inventory optimizationTender outcomes, launch dates and generic entry are logged as named assumptions with an owner and a date, and each one is scored against what happened in the next cycle.
Explore IBPSuppliers of active ingredients, excipients and packaging components are mapped below the first tier as far as your bill of materials and supplier records go. Each single source is flagged with the revenue it holds up.
Explore supplier riskHow Pharma and Biotech Planning Connects
A country pack forecast reaches back through packaging and manufacturing to the inputs behind them.
Country Forecast
- Tender calendar
- Launch dates
- Generic entry
Market Stock
- Service targets
- Remaining shelf life
- Short-dated packs
Pack Plan
- Country packs
- Packaging lines
- Changeovers
Campaign Plan
- Drug substance
- Formulation
- Contract manufacturers
Brand and Market P&L
- Net sales
- Expiry write-offs
- Working capital
Built for Pharma and Biotech
Pharma and biotech planning follows each batch from drug substance to the country pack it ends in.
Outside Sites Planned Like Your Own
Contract manufacturers carry their own capacity, lead times, minimum batch sizes and cost in the same finite-capacity solve.
Tenders and Generic Entry Scored
Each assumption about a tender, launch or generic entry has an owner and a date, and the next cycle checks it against the outcome.
Short-Dated Packs Caught Early
Remaining shelf life is visible for each market pack, so stock packed for a slow market is flagged while it still has time to sell.
One Forecast for Every Market
Market teams and supply planners work in one consensus forecast, where every edit carries its author and a score against the model.
Planning Notes for Pharma and Biotech
See all notes
The single source hiding behind a perfectly healthy supplier
Sub-tier supplier risk hides behind healthy tier one scorecards. Building the map without full disclosure, entity resolution, and acting on a concentration.
20 August 202610 min read
What the master production schedule settles before anything explodes
How forecast consumption and the demand time fence turn a demand plan into a buildable statement, the two ways that arithmetic goes wrong, and what the schedule owes order management.
27 August 20268 min read
The assumptions nobody wrote down are the ones that broke the plan
Planning assumptions management with a scored ledger: what belongs in it, how to score entries next cycle, and how to keep it small enough to survive.
22 August 20269 min readPharma and Biotech Planning FAQs
Can DemandLabs plan biologics and small molecules together?
Both run on the same model. Each product carries its own line capacity, changeovers, minimum batch sizes and lead times, so biologic campaigns and tablet lines share one plan.
How are tenders and generic entry handled?
A tender result or a generic entry date goes into the plan as a named assumption. Scenario rooms compare the plans with and without it on P&L, cash and service.
Can we see which market packs are getting short-dated?
Expiry dates and remaining shelf life feed the aging view for each market pack, and stock nearing its date gets a recovery play while it can still be sold.
How long does implementation take?
Eight weeks to the first live cycle for one planning area, with a value review with your CFO in week 10.
More Life Sciences Segments
All life sciences planningSee Your Market Packs Planned Against Expiry
A 45-minute walkthrough on your own data.